Beauty Health (SKIN)
Beauty Health Statistics
Share Statistics
Beauty Health has 125.99M shares outstanding. The number of shares has increased by 1.3% in one year.
| Shares Outstanding | 125.99M |
| Shares Change (YoY) | 1.3% |
| Shares Change (QoQ) | 0.9% |
| Owned by Institutions (%) | 59.04% |
| Shares Floating | 73.86M |
| Failed to Deliver (FTD) Shares | 3.45K |
| FTD / Avg. Volume | 0.54% |
Short Selling Information
The latest short interest is 7.78M, so 6.22% of the outstanding shares have been sold short.
| Short Interest | 7.78M |
| Short % of Shares Out | 6.22% |
| Short % of Float | 14.99% |
| Short Ratio (days to cover) | 8.68 |
Valuation Ratios
The PE ratio is -6.77 and the forward PE ratio is -4.72. Beauty Health's PEG ratio is 0.07.
| PE Ratio | -6.77 |
| Forward PE | -4.72 |
| PS Ratio | 0.59 |
| Forward PS | 0.3 |
| PB Ratio | 3.8 |
| P/FCF Ratio | 21.08 |
| PEG Ratio | 0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Beauty Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7, with a Debt / Equity ratio of 10.97.
| Current Ratio | 7 |
| Quick Ratio | 5.99 |
| Debt / Equity | 10.97 |
| Debt / EBITDA | 39.07 |
| Debt / FCF | 60.83 |
| Interest Coverage | -6.51 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $434.71K |
| Profits Per Employee | $-37.84K |
| Employee Count | 769 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.2 |
Taxes
| Income Tax | -452K |
| Effective Tax Rate | 1.53% |
Stock Price Statistics
The stock price has increased by -67.8% in the last 52 weeks. The beta is 0.85, so Beauty Health's price volatility has been higher than the market average.
| Beta | 0.85 |
| 52-Week Price Change | -67.8% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 1.5 |
| Relative Strength Index (RSI) | 46.05 |
| Average Volume (20 Days) | 635.85K |
Income Statement
In the last 12 months, Beauty Health had revenue of 334.29M and earned -29.1M in profits. Earnings per share was -0.05.
| Revenue | 334.29M |
| Gross Profit | 182.3M |
| Operating Income | -67.77M |
| Net Income | -29.1M |
| EBITDA | 14.54M |
| EBIT | -19.14M |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has 370.06M in cash and 568.16M in debt, giving a net cash position of -198.09M.
| Cash & Cash Equivalents | 370.06M |
| Total Debt | 568.16M |
| Net Cash | -198.09M |
| Retained Earnings | -507.96M |
| Total Assets | 685.68M |
| Working Capital | 408.95M |
Cash Flow
In the last 12 months, operating cash flow was 16.13M and capital expenditures -6.79M, giving a free cash flow of 9.34M.
| Operating Cash Flow | 16.13M |
| Capital Expenditures | -6.79M |
| Free Cash Flow | 9.34M |
| FCF Per Share | 0.08 |
Margins
Gross margin is 54.53%, with operating and profit margins of -20.27% and -8.7%.
| Gross Margin | 54.53% |
| Operating Margin | -20.27% |
| Pretax Margin | -8.84% |
| Profit Margin | -8.7% |
| EBITDA Margin | 4.35% |
| EBIT Margin | -20.27% |
| FCF Margin | 2.79% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SKIN is $2, which is 92.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $2 |
| Price Target Difference | 92.3% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
Scores
| Altman Z-Score | 0.19 |
| Piotroski F-Score | 7 |